These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20518132)

  • 1. First signs of glaucoma injury occur in the brain. What has generally been considered an eye disease is actually related to conditions such as Alzheimer's and Parkinson's diseases.
    Duke Med Health News; 2010 May; 16(5):4-5. PubMed ID: 20518132
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship.
    Calne DB; Eisen A
    Adv Neurol; 1990; 53():355-60. PubMed ID: 2239477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Parkinson's disease accompanied by dementia--a case of concurrent Parkinson's and Alzheimer's diseases (author's transl)].
    Sugimura K; Yamasaki Y; Ando K
    Rinsho Shinkeigaku; 1977 Aug; 17(8):513-9. PubMed ID: 923169
    [No Abstract]   [Full Text] [Related]  

  • 4. The aging eye: common degenerative mechanisms between the Alzheimer's brain and retinal disease.
    Sivak JM
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):871-80. PubMed ID: 23364356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia.
    Xuereb JH; Tomlinson BE; Irving D; Perry RH; Blessed G; Perry EK
    Adv Neurol; 1990; 53():35-40. PubMed ID: 2173374
    [No Abstract]   [Full Text] [Related]  

  • 6. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR; Mann DM; Mountjoy CQ; Lees AJ
    Adv Neurol; 1990; 53():55-9. PubMed ID: 2173375
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-hydrolytic functions of acetylcholinesterase. The significance of C-terminal peptides.
    Greenfield SA; Zimmermann M; Bond CE
    FEBS J; 2008 Feb; 275(4):604-11. PubMed ID: 18205834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Parkinson's disease and Alzheimer's disease--similarities in magnetic resonance imaging parameters and their possible explanation].
    Ebmeier KP; Besson JA; Cherryman G; Smith F
    Z Gerontol; 1988; 21(3):142-5. PubMed ID: 3407284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.
    Langston JW; Sastry S; Chan P; Forno LS; Bolin LM; Di Monte DA
    Exp Neurol; 1998 Dec; 154(2):684-90. PubMed ID: 9878203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration.
    Libby RT; Anderson MG; Pang IH; Robinson ZH; Savinova OV; Cosma IM; Snow A; Wilson LA; Smith RS; Clark AF; John SW
    Vis Neurosci; 2005; 22(5):637-48. PubMed ID: 16332275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is leuko-araiosis in Alzheimer's disease, in Parkinson's disease and in healthy elderly persons the result of Wallerian degeneration?].
    Leys D; Pruvo JP; Soetaert G; Vermersch P; Rapoport A; Clarisse J; Petit H
    Acta Neurol Belg; 1989; 89(3-4):249-52. PubMed ID: 2516973
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuropathological substrates of Alzheimer's disease and Parkinson's disease.
    Jellinger K
    J Neural Transm Suppl; 1987; 24():109-29. PubMed ID: 3316494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disentangling the genetic overlap and causal relationships between primary open-angle glaucoma, brain morphology and four major neurodegenerative disorders.
    Diaz-Torres S; He W; Thorp J; Seddighi S; Mullany S; ; Hammond CJ; Hysi PG; Pasquale LR; Khawaja AP; Hewitt AW; Craig JE; Mackey DA; Wiggs JL; van Duijn C; Lupton MK; Ong JS; MacGregor S; Gharahkhani P
    EBioMedicine; 2023 Jun; 92():104615. PubMed ID: 37201334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis.
    Altamura S; Muckenthaler MU
    J Alzheimers Dis; 2009; 16(4):879-95. PubMed ID: 19387120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter.
    Hartmann A; Hunot S; Hirsch EC
    Exp Neurol; 2003 Dec; 184(2):561-4. PubMed ID: 14769349
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuronal filaments in Alzheimer's, Pick's, and Parkinson's diseases.
    Kahn J; Anderton BH; Gibb WR; Lees AJ; Wells FR; Marsden CD
    N Engl J Med; 1985 Aug; 313(8):520-1. PubMed ID: 4040609
    [No Abstract]   [Full Text] [Related]  

  • 18. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease.
    Arendt T; Brückner MK; Bigl V; Marcova L
    J Comp Neurol; 1995 Jan; 351(2):189-222. PubMed ID: 7535318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modern hypothesis: The distinct pathologies of dementia associated with Parkinson's disease versus Alzheimer's disease.
    Farlow MR; Cummings J
    Dement Geriatr Cogn Disord; 2008; 25(4):301-8. PubMed ID: 18311077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in the pathology of Parkinson's disease.
    Jellinger K
    Adv Neurol; 1990; 53():1-16. PubMed ID: 1978509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.